Daniela Russo
6PUBLICATIONS
47CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 19, 2025
CCDC6 Immunostaining in Conjunction with the Rad51 HRD Assay May Expand PARPi Treatment Eligibility in Patients with HGSOC.Daniela Criscuolo, Francesco Merolla, Benedetta Pellegrino
|Sep 23, 2022
Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab.Marina Fabbi, Delfina Costa, Daniela Russo
|Apr 12, 2022
Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients.Crescenzo D'Alterio, Anna Spina, Laura Arenare
|Jan 21, 2022
AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization.Eros Azzalini, Domenico Tierno, Michele Bartoletti
|Aug 18, 2020
PARP Inhibitors in Endometrial Cancer: Current Status and Perspectives.Lucia Musacchio, Giuseppe Caruso, Carmela Pisano
|Apr 11, 2020
Ovarian Cancer Translational Activity of the Multicenter Italian Trial in Ovarian Cancer (MITO) Group: Lessons Learned in 10 Years of Experience.Daniela Califano, Daniela Russo, Giosuè Scognamiglio
Pageof 1
Frequent Collaborators
5 joint publications
Daniela Califano
2 joint publications
Delia Mezzanzanica
2 joint publications
Sandro Pignata
2 joint publications
Giosuè Scognamiglio
2 joint publications
Vincenzo Canzonieri
2 joint publications
Simona Signoriello
2 joint publications
Paolo Chiodini
1 joint publications
Loris De Cecco
1 joint publications
Giuseppe Caruso
1 joint publications
Innocenza Palaia
